You are here

Article info

Article menu

Download PDFPDF

E-Poster Presentation
6. SLE etiology & pathogenesis
LP-094 Repression of Id3 aggravates lupus phenotypes in murine models via aberrant B cell differentiation

Authors

  • Youngjae Park Department of Internal Medicine, Seoul St. Mary’s hospital, The Catholic University of Korea, Republic of Korea PubMed articlesGoogle scholar articles
  • Da Som Kim The Rheumatism Research Center, The Catholic University of Korea, Republic of Korea Department of Biomedicine and Health Sciences, College of Medicine, The Catholic University of Korea, Republic of Korea PubMed articlesGoogle scholar articles
  • Mi-La Cho The Rheumatism Research Center, The Catholic University of Korea, Republic of Korea PubMed articlesGoogle scholar articles
  • Seung-Ki Kwok Department of Internal Medicine, Seoul St. Mary’s hospital, The Catholic University of Korea, Republic of Korea The Rheumatism Research Center, The Catholic University of Korea, Republic of Korea PubMed articlesGoogle scholar articles

Citation

Park Y, Kim DS, Cho M, et al
LP-094 Repression of Id3 aggravates lupus phenotypes in murine models via aberrant B cell differentiation
Lupus Science & Medicine 2023;10:doi: 10.1136/lupus-2023-KCR.198

Publication history

  • First published August 6, 2023.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.